HEFA Hydroprocessing Patents: Who Leads, Where the Gaps Are 2026
- Leader holds 573 families, yet the top 5 combined account for only 16.7% of all 10,125 records in scope — concentration at the top, long tail beneath it.
- Filings peaked in 2018 at 394 and have declined since, with 2026 figures still partial due to publication lag.
- Medicinal and food IPC classes dominate, with A61K at 28.1% and A23L at 20.3% of records, ahead of core fuel-processing classes like C11B at 11.7%.
Filing growth compares 2021 (303 records) with 2024 (154) — a three-year span. 2024 is the most recent year we treat as complete: publication lags filing by roughly 18 months, so 2025 onwards are still filling in and any growth rate that ends there would understate the field. Top-5 share is the combined record count of the five largest assignees divided by all 10,125 records in scope (CR5), not by the ranked leaders only.
What this landscape covers
HEFA — hydroprocessed esters and fatty acids — converts vegetable oils, animal fats and used cooking oil into paraffinic hydrocarbons through deoxygenation, isomerization and hydrotreating. This landscape draws on 10,125 published patent records filed between 2015 and mid-2026 that combine HEFA-specific terminology with technical claim language covering deoxygenation, isomerization catalysts, feedstock impurities, phosphorus management, hydrogen consumption, cold flow properties and co-processing with conventional refinery streams.
The dataset spans records filed across major receiving offices including the United States, the European Patent Office, WIPO's PCT system, Canada, Australia and the United Kingdom, reflecting a technology with both refining and agricultural-feedstock roots.
Filing trends and technology composition
Two views of the same 10,125 records: how filing activity has moved year over year, and which IPC subclasses carry the claim density.
Filing trend: a peak already behind us
Filings rose from 315 in 2017 to a peak of 394 in 2018, then eased toward a 2022 midpoint of 187 and continued lower — a flat-to-declining pattern rather than sustained growth. The 2026 figure of 10 is a partial year and understates true filing activity given the roughly 18-month lag between filing and publication.
IPC composition: fuel chemistry sits behind food and pharma classes
A61K (medicinal preparations) leads at 28.1% of the 10,125 records, with A23L (foods and beverages) at 20.3% close behind. Classes tied more directly to fuel processing — C11B (fatty oils and waxes production) at 11.7% and C07C (acyclic and carbocyclic compounds) at 14.0% — sit lower, indicating that much of the surrounding patent activity originates in nutraceutical and food-science filings rather than pure fuel refining.
Shares are the percentage of the 10,125 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.
Go deeper on HEFA Hydroprocessing of Fats and Oils with Eureka
This page is one run against one query. Ask Eureka your own question about hefa hydroprocessing of fats and oils and every answer comes back with the patent numbers behind it.
Try EurekaRepresentative filing and most-cited prior art
SG169699B — Method for manufacturing a hydrocarbon oil
Filed by JX Nippon Oil & Energy Corporation, this record addresses conversion of biomass-derived animal or vegetable oil into hydrocarbon fuel, framed around the carbon-neutrality rationale for biomass energy utilisation in transportation fuel. It sits within the broader deoxygenation and hydroprocessing claim space that much of this landscape's fuel-processing activity occupies.Abstract text truncated as provided in the underlying record.
View full record| # | Publication no. | Patent title | Citations |
|---|---|---|---|
| 1 | US5130242A | Process for the heterotrophic production of microbial products with high concentrations of omega-3 highly uns… | 1,010 |
| 2 | US4741855A | Shampoo compositions | 1,010 |
| 3 | US4992605A | Production of hydrocarbons with a relatively high cetane rating | 846 |
| 4 | EP1741768A1 | Process for the manufacture of diesel range hydrocarbons | 665 |
| 5 | US5194654A | Lipid derivatives of phosphonoacids for liposomal incorporation and method of use | 583 |
| 6 | US20040230085A1 | Process for producing a hydrocarbon component of biological origin | 569 |
| 7 | US5223263A | Liponucleotide-containing liposomes | 557 |
| 8 | US5006170A | Hot melt ink compositions | 527 |
| 9 | US6887906B1 | Compositions and methods for the delivery of oligonucleotides via the alimentary canal | 525 |
| 10 | WO2007136762A2 | Production of fatty acids and derivatives thereof | 491 |
Citation counts favour older filings that have had more time to accumulate citations within this searched corpus; treat them as signals of influence, not of current commercial relevance.
Each row carries its publication number; clicking a row searches Eureka by that number.
Put your own technology through the same analysis
Eureka on the web
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →MCP server & REST API
When it has to run inside your own pipeline.
Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.
Browse MCP servers →What the data means for a filing decision
Three patterns stand out once family counts, trend direction and IPC shares are read together.
A leader, then a long tail
The leading assignee holds 573 families, well ahead of fifth place at 164 and tenth place at 117. Yet the top 5 combined reach only 16.7% of all 10,125 records, and the top 10 only 23.2% — this is a field with one clear leader but no oligopoly beneath it, leaving room for new entrants to build meaningful positions.
Filing activity has cooled since 2018
Activity rose to a peak of 394 filings in 2018, then declined through a 2022 midpoint of 187. This is not a growth story; it reads as a maturing claim landscape where the earliest and broadest process claims have already been staked out.
Fuel processing sits inside a wider bioscience footprint
Medicinal preparations (A61K) and food classes (A23L, A23K) together outweigh the core fuels classes (C11B, C07C), showing that fatty-acid hydroprocessing claim space overlaps heavily with nutraceutical and feed applications rather than standing as an isolated fuels category.
Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to hefa hydroprocessing of fats and oils, with the prior art for and against each one.
Who holds the ground, and where it is still open
The ranked assignee list covers 100 companies; most hold single-digit family counts, with concentration limited to a handful of names at the top.
One assignee well ahead of the field
The leading assignee's 573 families sit far above the rest of the ranking, but this scale has not translated into a dominant share of the whole field — the remaining leaders each hold well under half that count.
A small collaborative cluster around agricultural research
The strongest co-assignee pairing links two research organisations at 144 shared records, with a second cluster of feedstock and nutrition-focused entities co-filing at 61 records each — evidence of joint feedstock or agronomic research programmes rather than pure fuel-processing partnerships.
Recent-year filing has slowed across the top names
Momentum data shows the most active recent filer dropping to a single filing in the latest year, down 50% year over year, while several other leading assignees show no recorded filings in the latest year — consistent with the broader post-2018 decline rather than an isolated retreat.
| Assignee | Recent year | YoY |
|---|---|---|
| Neste Oyj | 1 | -50% |
| Abbott Laboratories | 0 | — |
| Commonwealth Scientific and Industrial Research Organisation (CSIRO) | 0 | — |
| DSM IP Assets B.V. | 0 | — |
| Nestec S.A. | 0 | — |
| Grains Research & Development Corporation | 0 | — |
| Chevron U.S.A. Inc. | 0 | -100% |
| Nuseed Pty Ltd | 0 | -100% |
Where to take this from here
The landscape points to specific next steps depending on whether the goal is freedom-to-operate, licensing or new filing strategy.
Check freedom-to-operate against the leader's portfolio
With one assignee holding 573 families, any commercial-scale HEFA process should be screened against that portfolio specifically, not just the general prior art, before committing to a catalyst or feedstock route.
Explore assignee portfolios in EurekaWatch the under-claimed process branches
Cold flow tuning, phosphorus management and co-processing ratios show thinner filing density than core deoxygenation claims, suggesting room for defensible new filings in these specific sub-areas.
Run a white space search in EurekaTreat citation leaders as prior art anchors, not current benchmarks
The most-cited records in this corpus date from the 1980s and 1990s; use them to understand foundational claim scope, then verify against more recent filings for current freedom-to-operate.
Review cited prior art in EurekaCommon questions on HEFA hydroprocessing patents
HEFA stands for hydroprocessed esters and fatty acids, a process that converts triglyceride feedstocks such as vegetable oils, animal fats and used cooking oil into paraffinic hydrocarbon fuel through catalytic deoxygenation and isomerization. It differs from processes like Fischer-Tropsch synthesis or alcohol-to-jet in that it starts from lipid feedstocks rather than syngas or ethanol. In this patent dataset, HEFA-specific claim language overlaps heavily with food, feed and pharmaceutical classifications because the underlying fatty-acid chemistry is shared across those applications.
The ranked assignee list covers 100 companies, with one clear leader holding 573 families — well ahead of fifth place at 164 and tenth place at 117. However, the top 5 assignees combined account for only 16.7% of all 10,125 records in scope, and the top 10 for 23.2%, meaning there is no small group controlling the field. A long tail of single- and few-filing entrants holds the remainder, which matters for anyone assessing competitive risk beyond the largest few names.
No — filing activity peaked in 2018 at 394 records and has declined since, reaching a midpoint of 187 in 2022 and continuing lower. This pattern suggests the broadest early process claims around deoxygenation and isomerization have already been filed, and that current activity is more incremental. The most recent year's figures are partial because publication typically lags filing by around 18 months, so the true recent trend is likely somewhat higher than shown.
Filing density is comparatively thin in specific sub-areas including phosphorus removal from variable feedstocks, cold flow property tuning through isomerization catalyst design, co-processing ratio optimisation with conventional diesel streams, and impurity tolerance for waste-oil feedstocks. These sit adjacent to the dense core deoxygenation and catalyst claims but are not as heavily occupied. A first claim in these areas would likely need to tie a specific catalyst formulation or process parameter to a measurable feedstock or fuel-property outcome to clear the existing art.
This landscape counts 10,125 patent families rather than raw publication counts, which is the fairer unit because it neutralises the effect of continuations and multi-jurisdiction filing by the same applicant. Receiving office data shows the United States, European Patent Office and WIPO's PCT system as the largest venues, with Canada, Australia and the United Kingdom also well represented. Using families rather than raw filings avoids overstating the activity of applicants that file aggressively across jurisdictions for the same invention.
Research HEFA Hydroprocessing of Fats and Oils in depth with Eureka
Go past this page: query the whole hefa hydroprocessing of fats and oils corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.
Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.
Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company’s registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.